Ferric carboxymaltose
- Generic Name
- Ferric carboxymaltose
- Brand Names
- Injectafer
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9007-72-1
- Unique Ingredient Identifier
- 6897GXD6OE
- Background
Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.
- Indication
Ferric carboxymaltose is an iron replacement product indicated for the treatment of iron deficiency anemia in patients ≥1 year of age who have an intolerance to, or unsatisfactory response from, oral iron therapy. It is also indicated in adult patients who have non-dialysis-dependent chronic kidney disease.
- Associated Conditions
- Iron Deficiency Anemia (IDA)
- Associated Therapies
- -
Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial
- Conditions
- Interventions
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 40
- Registration Number
- NCT03050424
- Locations
- 🇬🇧
Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom
Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency
- Conditions
- Interventions
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2018-02-28
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Registration Number
- NCT03042130
- Locations
- 🇮🇱
Department of internal medicine A, Tel-Aviv, Israel
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
- Conditions
- Interventions
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 3065
- Registration Number
- NCT03037931
- Locations
- 🇺🇸
NEA Baptist Clinic, Jonesboro, Arkansas, United States
🇺🇸Richmond University Medical Center, Staten Island, New York, United States
🇦🇺SWSLHD-Liverpool Hospital, Liverpool, New South Wales, Australia
Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
- First Posted Date
- 2016-10-31
- Last Posted Date
- 2020-04-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT02949947
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
- Conditions
- Interventions
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- Vifor (International) Inc.
- Target Recruit Count
- 1132
- Registration Number
- NCT02937454
- Locations
- 🇸🇪
Skane University Hospital, Malmö, Sweden
🇦🇷Hospital Universitario Austral, Buenos Aires, Argentina
🇭🇷Clinical Hospital Center Rijeka, Rijeka, Croatia
A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
- Conditions
- Interventions
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- Universität des Saarlandes
- Target Recruit Count
- 26
- Registration Number
- NCT02905539
- Locations
- 🇩🇪
Universitätsklinikum des Saarlandes, Homburg, Saarland, Germany
Intravenous Iron Pre-treatment in Prognathic Surgery
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Konkuk University Medical Center
- Target Recruit Count
- 48
- Registration Number
- NCT02800746
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Bayside Health
- Target Recruit Count
- 955
- Registration Number
- NCT02632760
- Locations
- 🇦🇺
Alfred Health, Melbourne, Victoria, Australia
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
- Conditions
- Interventions
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Ifakara Health Institute
- Target Recruit Count
- 230
- Registration Number
- NCT02541708
- Locations
- 🇹🇿
Ifakara Health Institute, Bagamoyo, Tanzania
Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
- Conditions
- Interventions
- First Posted Date
- 2015-08-06
- Last Posted Date
- 2015-09-10
- Lead Sponsor
- Istituto Clinico Humanitas
- Target Recruit Count
- 36
- Registration Number
- NCT02517151
- Locations
- 🇮🇹
IBD Center, Rozzano, MI, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.